Claes Lindh

Claes Lindh

Auto-generated profile, based on publicly available information

Claes Lindh

Department of Oncology‐Pathology Karolinska Institutet Stockholm Sweden

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Cancer Letters
Verified
Journal Article
Closed access
GKGovindasamy-Muralidharan Karthik
Govindasamy-Muralidharan Karthik
RMRan Ma
Ran Ma
JLJohn Lövrot
John Lövrot
LKLorand Levente Kis
Lorand Levente Kis
CLClaes Lindh
Claes Lindh
JHJohan Hartman
Johan Hartman

20 January 2022 in The Prostate
Verified
Journal Article
Open access
PDF file
CLClaes Lindh
Claes Lindh
HSHemamali Samaratunga
Hemamali Samaratunga
BDBrett Delahunt
Brett Delahunt
RBRebecka Bergström
Rebecka Bergström
VCVenkatesh Chellappa
Venkatesh Chellappa
LELars Egevad
Lars Egevad
Background: Ductal adenocarcinoma (DA) is an aggressive subtype of prostate cancer. It is most commonly seen in mixed tumors together with conventional acinar adenocarcinoma (AA). The genetic profile of DA and its clonal origin is not fully characterized.Objective: To investigate whether DA represents a distinct genetic subtype and to investigate the somatic relationship between the ductal and acinar components of mixed cancers.Design, Setting, and Participants: In 17 radical prostatectomy specimens ductal and acinar tumor components from the same tumor foci were dissected. DNA was extracted and genomic sequencing performed. After exclusion of two cases with low cell yield, 15 paired samples remained for analysis.Results: In 12 of 15 cases a common somatic denominator was identified, while three cases had clonally separate components. In DA, TMPRSS2‐ERG gene fusions were detected in 47% (7/15), clonal FOXA1 alterations in 33% (5/15) and SPOP alterations in 27% (4/15) of cases. In one case KIAA1549−BRAF fusion was identified. Genome doubling events, resulting in an increased ploidy, were identified in the DA in 53% (8/15) of cases, but not seen in any AA. PTEN and CTNNB1 alterations were enriched in DA (6/15) but not seen in any AA. No cancers showed microsatellite instability or high tumor mutation burden.Conclusions: Ductal and acinar prostate adenocarcinoma components of mixed tumors most often share the same origin and are clonally related. DA components in mixed tumor often exhibit genome doubling events resulting in aneuploidy, consistent with the aggressive nature of high grade prostate cancer.

7 September 2017 in Histopathology
Verified
Journal Article
Closed access
PDF file
CLClaes Lindh
Claes Lindh
BDBrett Delahunt
Brett Delahunt
HSHemamali Samaratunga
Hemamali Samaratunga
JYJohn W. Yaxley
John W. Yaxley
JGJóna Gudjónsdóttir
Jóna Gudjónsdóttir
LELars Egevad
Lars Egevad